Clinical and Radiographic Outcomes in Patients Diagnosed with Early Rheumatoid Arthritis in the First Years of the Biologic Treatment Era: A 10-year Prospective Observational Study

From the Department of Rheumatology, Hospital of Southern Norway Trust, Kristiansand; Norwegian University of Science and Technology, Trondheim; Department of Rheumatology, Diakonhjemmet Hospital, Oslo; Department of Rheumatology, Martina Hansens Hospital, Bærum, Norway. Supported by an unrestricted grant to Martina Hansens Hospital from Pfizer Norway. G. Haugeberg, MD, PhD, consultant, Department of Rheumatology, Hospital of Southern Norway Trust, professor, Norwegian University of Science and Technology; P. Bøyesen, MD, PhD, assistant doctor, Department of Rheumatology, Diakonhjemmet Hospital; K. Helgetveit, MD, Department of Rheumatology, Martina Hansens Hospital; A. Prøven, MD, Department of Rheumatology, Martina Hansens Hospital. Address correspondence to Prof. G. Haugeberg, Department of Rheumatology, Martina Hansens Hospital, Postbox 823, N-1306 Sandvika, Norway. E-mail: glenn.haugeberg@mhh.no. Accepted for publication August 14, 2015.

From the Department of Rheumatology, Hospital of Southern Norway Trust, Kristiansand; Norwegian University of Science and Technology, Trondheim; Department of Rheumatology, Diakonhjemmet Hospital, Oslo; Department of Rheumatology, Martina Hansens Hospital, Bærum, Norway. Supported by an unrestricted grant to Martina Hansens Hospital from Pfizer Norway. G. Haugeberg, MD, PhD, consultant, Department of Rheumatology, Hospital of Southern Norway Trust, professor, Norwegian University of Science and Technology; P. Bøyesen, MD, PhD, assistant doctor, Department of Rheumatology, Diakonhjemmet Hospital; K. Helgetveit, MD, Department of Rheumatology, Martina Hansens Hospital; A. Prøven, MD, Department of Rheumatology, Martina Hansens Hospital. Address correspondence to Prof. G. Haugeberg, Department of Rheumatology, Martina Hansens Hospital, Postbox 823, N-1306 Sandvika, Norway. E-mail: glenn.haugeberg@mhh.no. Accepted for publication August 14, 2015.

From the Department of Rheumatology, Hospital of Southern Norway Trust, Kristiansand; Norwegian University of Science and Technology, Trondheim; Department of Rheumatology, Diakonhjemmet Hospital, Oslo; Department of Rheumatology, Martina Hansens Hospital, Bærum, Norway. Supported by an unrestricted grant to Martina Hansens Hospital from Pfizer Norway. G. Haugeberg, MD, PhD, consultant, Department of Rheumatology, Hospital of Southern Norway Trust, professor, Norwegian University of Science and Technology; P. Bøyesen, MD, PhD, assistant doctor, Department of Rheumatology, Diakonhjemmet Hospital; K. Helgetveit, MD, Department of Rheumatology, Martina Hansens Hospital; A. Prøven, MD, Department of Rheumatology, Martina Hansens Hospital. Address correspondence to Prof. G. Haugeberg, Department of Rheumatology, Martina Hansens Hospital, Postbox 823, N-1306 Sandvika, Norway. E-mail: glenn.haugeberg@mhh.no. Accepted for publication August 14, 2015.

From the Department of Rheumatology, Hospital of Southern Norway Trust, Kristiansand; Norwegian University of Science and Technology, Trondheim; Department of Rheumatology, Diakonhjemmet Hospital, Oslo; Department of Rheumatology, Martina Hansens Hospital, Bærum, Norway. Supported by an unrestricted grant to Martina Hansens Hospital from Pfizer Norway. G. Haugeberg, MD, PhD, consultant, Department of Rheumatology, Hospital of Southern Norway Trust, professor, Norwegian University of Science and Technology; P. Bøyesen, MD, PhD, assistant doctor, Department of Rheumatology, Diakonhjemmet Hospital; K. Helgetveit, MD, Department of Rheumatology, Martina Hansens Hospital; A. Prøven, MD, Department of Rheumatology, Martina Hansens Hospital. Address correspondence to Prof. G. Haugeberg, Department of Rheumatology, Martina Hansens Hospital, Postbox 823, N-1306 Sandvika, Norway. E-mail: glenn.haugeberg@mhh.no. Accepted for publication August 14, 2015.